Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Misoprostol 600 mcg vs 800 mcg for induced abortion in early pregnancy loss
TCTR20210303009Phase 4Completed
- Sponsor
- No
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of misoprostol in Early pregnancy failure (EPF) (2 arms), sponsored by No. Started Apr 2020; status: completed.
02
Drugs
misoprostol
03
Conditions
Early pregnancy failure (EPF)
Beyond the preview
Go deeper on TCTR20210303009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210303009.